Piramal Pharma (PPLPHARMA) — Insider Trading

Promoter Ajay G. Piramal disclosed no share encumbrances on Piramal Pharma Limited during FY 2025-26 per SEBI SAST Regulation 31(4). This confirms promoter group maintains full share pledge integrity with no new encumbrances created in the reporting year.

📄 View Original Announcement (PDF)

📊 Stock Analysis — PPLPHARMA ✨ Ask AI About This

About Piramal Pharma Limited (PPLPHARMA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹23,244.56 Cr P/E: 582.9

View full PPLPHARMA stock details →

📡 Get AI alerts when PPLPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track PPLPHARMA — Free

💡 Ask AI about this filing

"How does this insider trading affect Piramal Pharma Limited's outlook?" "What did Piramal Pharma Limited announce on 29 June 2026?" "Is this positive or negative for PPLPHARMA?"

Ask AI Free →

📊 More PPLPHARMA filings

See all PPLPHARMA filings →

🔥 Also filed on 29 June 2026

ROSSTECH Rossell Techsys Limited Announcement SAIL Steel Authority of India Limited Insider Trading PROZONER Prozone Realty Limited Insider Trading ROLEXRINGS Rolex Rings Limited Corporate Action RML Rane (Madras) Limited Announcement SANGINITA Sanginita Chemicals Limited Offer Document

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when PPLPHARMA files new disclosures

Track PPLPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.